+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 40Years +
FEMALE
ID04666961

Neoadjuvant Hormone Therapy with Tamoxifen or Anastrozole for Women Over 40 with Extensive Ductal Carcinoma In Situ Facing Mastectomy

Led by Institut Cancerologie de l'Ouest · Updated on 2022-04-22

262

Participants Needed

8

Research Sites

469 weeks

Total Duration

AI-Summary

What This Trial Is About

Ductal carcinoma in situ DCIS makes up about 20% of new breast cancer diagnoses, with around 20% of these cases requiring mastectomy due to extensive lesions, often appearing as widespread microcalcifications. This aggressive surgery contrasts with the generally good prognosis of DCIS and can significantly affect patients quality of life. Researchers are studying neoadjuvant hormone therapy as a way to reduce the need for mastectomy by shrinking tumors before surgery in hormone receptor-positive DCIS cases. Participants will receive 6 months of hormone therapy with either Tamoxifen for premenopausal women or Anastrozole for postmenopausal women before surgery. Treatment is given orally with Tamoxifen at 20 mg daily or Anastrozole at 1 mg daily. Imaging tests, including mammography, ultrasound, and MRI, will monitor tumor response at 3 and 6 months. Surgery type mastectomy or tumorectomy will depend on tumor shrinkage, followed by sentinel node detection and possible axillary dissection based on node results. Patients undergo screening with clinical exams, imaging, and biopsies before starting therapy. Biomarker and tumor environment analysis will be done before and after treatment. Post-surgery, patients have follow-ups including imaging and quality of life questionnaires at set intervals up to 10 years. Outcome measures focus on hormone therapy effectiveness after 6 months, disease-free and overall survival at 5 and 10 years, and quality of life over time.

CONDITIONS

Brief Title

Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ

Research Team

V

Victoire BRILLAUD-MEFLAH, MD

E

Emilie DEBEAUPUIS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here